Home

About Us | Product Pipeline | Payload Technology | Discovery Platform | cGMP Manufacturing

Welcome to Viventia Biotechnologies Inc.

Viventia Biotechnologies Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of immunotoxin products offering safer and more beneficial cancer therapies. Viventia is employing its novel human antibody and target discovery platform and its proprietary payload, De-Bouganin, to create a portfolio of new antibody products directed at proprietary oncology drug targets.

The content of this site is for informational purposes only and is not intended to replace the advice of a health care professional.
Please consult your doctor if you have any questions regarding the information contained in this site. Viventia, the Viventia logo, Proxinium,
Vicinium, Unlock, Immunomine, Fusogenics, Power + Precision and Armed Antibodies are Trade Marks of Viventia Biotechnologies Inc.